Seizures in women with preeclampsia: Mechanisms and management

Fetal and Maternal Medicine Review

Volumn 22, Issue 2, 2011, Pages 91-108

  Cipolla, Marilyn J ^a   Kraig, Richard P ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; AQUAPORIN 4; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCERYL TRINITRATE; HYDRALAZINE; INTERCELLULAR ADHESION MOLECULE 1; LABETALOL; MAGNESIUM SULFATE; NICARDIPINE; NITROPRUSSIDE SODIUM; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENYTOIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ACIDOSIS; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; APHASIA; ARTERIAL WALL THICKNESS; ARTERY DIAMETER; ARTICLE; AUTOREGULATION; BLEEDING; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN EDEMA; CHEMOPROPHYLAXIS; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CONSCIOUSNESS DISORDER; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DRUG EFFICACY; DRUG SAFETY; ECLAMPSIA; FLUID THERAPY; FOCAL EPILEPSY; GRAND MAL SEIZURE; HEADACHE; HEMODYNAMICS; HUMAN; HYPOXIA; KIDNEY FAILURE; NERVE CELL EXCITABILITY; NEUROPATHOLOGY; NONHUMAN; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PROTEIN FUNCTION; RECEPTOR UPREGULATION; RESPIRATION DEPRESSION; SEIZURE; SIDE EFFECT; SOLUTIO PLACENTAE; TENDON REFLEX; TERATOGENICITY; TONIC CLONIC SEIZURE; TRAUMATIC BRAIN INJURY; VISUAL DISORDER;

EID: 79956102107     PISSN: 09655395     EISSN: 14695065     Source Type: Journal    
DOI: 10.1017/S0965539511000040     Document Type: Article

References (117)

1. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447-454.
2. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005; 105: 402-10. (Pubitemid 40229462)
3. Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ 1994; 309: 1395-400. (Pubitemid 24351401)
4. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990; 163: 460-465. (Pubitemid 20287609)
5. Möller B, LindmarkG. Eclampsia in Sweden, 1976-1980. ActaObstetGynecol Scand 1986; 65: 307-14. (Pubitemid 16059632)
6. Mattar F, Sibai BM. Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 2000; 182: 307-12. (Pubitemid 30127340)
7. Makhseed M, Musini VM. Eclampsia in Kuwait 1981-1993. Aust N Z J Obstet Gynaecol 1996; 36: 258-63. (Pubitemid 26278520)
8. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-37.
9. Katz VL, Farmer R, Kuller JA. Preeclampsia into eclampsia: toward a new paradigm. Am J Obstet Gynecol 2000; 182: 1389-396. (Pubitemid 30437405)
10. Servillo G, Striano P, Striano S. Posterior reversible encephalopathy syndrome (PRES) in obstetric critically ill patients. Intensive Care Med 2003; 29: 2323-326. (Pubitemid 38030688)
11. Gilmore E, Choi HA, Hirsch LJ, Claassen J. Seizures and CNS haemorrhage: spontaneous intracerebral and aneurysmal subarachnoid haemorrhage. Neurologist 2010; 16: 165-75.
12. Menon B, Shorvon SD. Ischaemic stroke in adults and epilepsy. Epilepsy Res 2009; 87: 1-11.
13. Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005; 46: 1724-743. (Pubitemid 44921957)
14. Holmes GL, Lenck-Santini PP. Role of interictal epileptiform abnormalities in cognitive impairment. Epilepsy Behav 2006; 8: 504-15.
15. Sabai BM. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990; 163: 1049-1055.
16. Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke 2009; 40: 1169-175.
17. Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: Evalauation of 235 cases. Am J Obstet Gynecol 1984; 148: 951-960.
18. Donaldson JO. Does magnesium sulfate treat eclamptic convulsions? Clinical Neuropharmacology 1986; 9: 37-45. (Pubitemid 16190500)
19. Kaplan PW, Lesser RP, Fisher RS, Repke JT, Hanley DF. No, magnesium sulfate should not be used in treating eclamptic seizures. Arch Neurol 1988; 45: 1361-364.
20. Zunker P, Happe S. Georgiadis AL, Louwen F, Georgiadis D, Ringelstein EB, Holgreve W. Maternal cerebral hemodynamics in pregnancy-related hypertension. A prospective transcranial Doppler study. Ultrasound Obstet Gynecol 2000; 16: 179-187. (Pubitemid 33111780)
21. Thomas SV. Neurologic aspects of eclampsia. J Neurol Sci 1998; 155: 37-43.
22. Easton DJ. Severe preeclampsia/eclampsia hypertensive encephalopathy of pregnancy? Cerebrovasc Dis 1998; 8: 53-58.
23. Fletcher JJ, Kramer AH, Bleck TP, Solenski NJ. Overlapping features of eclampsia and postpartum angiopathy. Neurocrit Care 2009; 11: 199-209.
24. Koch S, Rabinstein A, Falcone S, Forteza A. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia. Am J Neurorad 2001; 22: 1068-1070. (Pubitemid 32587417)
25. Kanki T, Tsukimori K, Mihara F, Nakano H. Diffusion-weighted images and vasogenic edema in eclampsia. Obstet Gynecol 1999; 93: 821-23. (Pubitemid 29197906)
26. Williams KP, Wilson S. Persistence of cerebral hemodynamic changes in patients with eclampsia: Areport of three cases. Am J Obstet Gynecol 1999; 181: 1162-165.
27. Manfredi M, Beltramello A, Bongiovanni LG, Polo A, Pistoia L, Rizzuto N. Eclamptic encephalopathy: imaging and pathogenetic considerations. Acta Neurol Scand 1997; 96: 277-82. (Pubitemid 27512500)
28. Schwartz RB, Jones KM, Kalina P, Gajakian RL, Mantello MT, Garada B, Holman BL. Hypertensive encephalopathy: findings on CT, MR-Imaging, and SPECT-Imaging in 14 cases. Am J Radiol 1992; 159:379-383.
29. Port JD, Beauchamp NJ. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 1998; 18: 253-67.
30. Servillo G, Striano P, Striano S. Posterior reversible encephalopathy syndrome (PRES) in obstetric critically ill patients. Intensive Care Med 2003; 29: 2323-326. (Pubitemid 38030688)
31. Engelter ST, Provenzale JM, Petrella JR. Assessment of vasogenic edema in eclampsia using diffusion imaging. Neuroradiology 2000; 42: 818-20.
32. Wityk RJ, PessinMS. Hypertensive Encephalopathy. In: Cerebrovascular Disease. H. Hunt Batjer, (eds). Lippincott Raven Publishers, Philadelphia, 1997; Ch. 8, pp.97-102.
33. Mirza A. Posterior reversible encephalopathy syndrome: A variant of hypertensive encephalopathy. J Clin Neurosci 2006; 13: 590-595. (Pubitemid 43850283)
34. Cipolla MJ, Sweet JG, Chan SL. Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J Appl Physiol 2010; 110: 329-339.
35. Demirtaşö, Gelal F, Dirim V, DemirtaşL O, UluçE, Baloǧlu A. Cranial MR imaging with clinical correlation in preeclampsia and eclampsia. Neuroradiology 2005; 11: 189-94. (Pubitemid 41748646)
36. Donaldson JO. The brain in eclampsia. Hypertens Pregnancy 1994; 13: 115-133. (Pubitemid 24276320)
37. Richards AM, Moodley J, Graham DI, Bullock MR. Active management of the unconscious eclamptic patient. Br J Obstet Gynecol 1986; 93: 554-62. (Pubitemid 16094086)
38. Richards AM, Graham DI, Bullock MR. Clinical pathological study of neurological complications due to hypertensive disorders of pregnancy. J Neurol Neurosurg Psychiatr 1988; 51: 416-21.
39. Sibai BM, Abdella TN, Spinnato JA, Anderson GD, Eclampsia V. The incidence of nonpreventable eclampsia. Am J Obstet Gynecol 1986; 154: 581-86.
40. Phillips SJ, Whisnant JP. Hypertension and the brain. Arch Intern Med 1992; 152: 938-45.
41. Euser AG, Cipolla MJ. Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats. Hypertension 2007; 49: 334-40. (Pubitemid 46143010)
42. Heistad DD, Kontos HA. In: Berne RM, Sperelakis N (eds.) The Cardiovascular System III. Handbook of Physiology American Physiological Society, Bethesda, MD, 1979; 137-82.
43. Busija DW, Heistad DD. Factors involved in the physiological regulation of the cerebral circulation. Rev Physiol Biochem Pharmacol 1984; 101: 161-11.
44. Johansson B, Li C-L, Olsson Y, Klatzo I. Effect of acute arterial hypertension on the blood-brain barrier to protein tracers. Acta Neuropath 1970; 16: 117-24.
45. Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, Patterson JL, Jr. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol 1978; 234: H371-H383. (Pubitemid 9125782)
46. Kontos HA,Wei EP, Dietrich WE, Navari RM, Povlishock JT, Ghatak NR et al. Mechanism of cerebral arteriolar abnormalities after acute hypertension. Am J Physiol 1981; 240: H511-H527. (Pubitemid 11150312)
47. Zatik J, Major R, Aranyozi J, Molnar C, Limburg M, Fulesdi B. Assessment of cerebral hemodynamics during roll over test in healthy, pregnant women and those with pre-eclampsia. Br J Obstet Gynaecol 2001; 108: 353-58. (Pubitemid 32269859)
48. Zeeman GG, HatabM, Twickler DM. Maternal cerebral blood flow changes in pregnancy.AmJObstet Gynecol 2003; 189: 968-72. (Pubitemid 37373879)
49. Cipolla MJ, Sweet JG, Thaler I.Maternal cerebral blood flow during normal pregnancy: a cross-sectional study. Am J Obstet Gynecol doi 10.1016/j.ajog.2010.05.031.
50. Donaldson JO. Eclamptic hypertensive encephalopathy. Semin Neurol 1988; 8: 230-33.
51. Zeeman GG, Hatab M, Twickler DM. Increased cerebral blood flow in preeclampsia with magnetic resonance imaging. Am J Obstet Gynecol 2004; 191: 1425-429. (Pubitemid 39421608)
52. Schwartz RB, Feske SK, Polak JF, DeGirolami U, Iaia A, Beckner KM et al. Pre-eclampsiaeclampsia: clinical and neuroradiologic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000; 217: 371-76.
53. Oehm E, Hetzel A, Els T, Berlis A, Keck C,Will H-G et al. Cerebral hemodynamics and autoregulation in reversible posterior leukoencephalopathy syndrome caused by pre-/eclampsia. Cerebrovasc Dis 2006; 22: 204-208. (Pubitemid 44114468)
54. Oehm E, Reinhard M, Keck C, Els T, Spreer J, Hetzel A. Impaired dynamic cerebral autoregulation in eclampsia. Ultrasound Obstet Gynecol 2003; 22: 395-98. (Pubitemid 37289769)
55. Sakamoto K, Saito T, Orman R, Koizumi K, Lazar J, Salciccioli L et al. Autonomic consequences of kainic acid-induced limbic cortical seizures in rats: peripheral autonomic nerve activity, acute cardiovascular changes, and death. Epilepsia 2008; 49: 982-96. (Pubitemid 351794001)
56. Simon RP, Aminoff MJ, Benowitz NL. Changes in plasma catecholamines after tonic-clonic seizures. Neurology 1984; 34: 255-57. (Pubitemid 14185384)
57. Nguyen-Lam J, Kiernan MC. Acute cortical blindness due to posterior reversible encephalopathy. J Clin Neurosci 2008; 15: 1182-185.
58. Wagner K, KlienholzM, de Courten-Myers G, Myers R. Hyperglycemic versus normoglycemic stroke: topography of brain metabolites, intracellular pH, and infarct size. J Cereb Blood Flow Metab 1992; 12: 213-22.
59. Betz AL, Dietrich WD. Blood-brain barrier dysfunction in cerebral ischaemia. In: Ginsberg MD, Bogousslavsky J (eds.) Cerebrovascular Disease: Pathophysiology, Diagnosis and Management Blackwell Science, Malden, MA; 1998, 358-370.
60. Wahl M, Unterberg A, Baethmann A, Schilling L. Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J Cereb Blood Flow Metab 1988; 8: 621-634.
61. Roberts TJ, Chapman AC, Cipolla MJ. PPAR-gamma agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension. Am J Physiol Heart Circ Physiol 2009; 297: H1347-H1353.
62. Dinsdale HB,Mohr JP. Hypertensive Encephalopathy. In: Barnett Henry JM, Mohr JP, BennetM, Stein Bennet M, Yatsu Frank M. (eds). Stroke. Pathophysiology, Diagnosis and Management 3rd edition. Churchill Livingston, New York, NY; 869-874
63. Cipolla MJ. Stroke and the Blood-Brain Interface. In: Spray D, Dermietzel R, Nedergaard M (eds) Blood-brain Barrier Interfaces. Wiley Press, Weinheim, 2006; 1-59
64. Pavlovsky L, Seiffert E, Heinemann U, Korn A, Golan H, Friedman A. Persistent BBB disruption may underlie alpha interferon-induced seizures. J Neurol 2005; 252: 42-46. (Pubitemid 40179017)
65. Marchi N, Teng Q, Ghosh C, Fan Q, Nguyen MT, Desai NK et al. Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity. Brain Res 2010; 1353: 176-86.
66. van Vliet EA, da Costa Araú jo S, Redeker S, van Schaik R, Aronica E, Gorter JA. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007; 130: 521-534. (Pubitemid 46181105)
67. Nag S, Robertson DM, Dinsdale HB. Quantitative estimate of pinocytosis in experimental acute hypertension. Acta Neuropathol (Berl) 1979; 46: 107-16. (Pubitemid 9246608)
68. Cipolla MJ, Crete R, Vitullo L, Rix RD. Transcellular transport as a mechanism of blood-brain barrier disruption during stroke. Front Biosci 2004; 9: 777-85. (Pubitemid 39043750)
69. Blum MS, Toninelli E, Anderson JM, Balda MS, Zhou J, O'Donnel L et al. Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am J Physiol 1997; 273: H286-H294.
70. Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci 1999; 22: 11-28. (Pubitemid 29144879)
71. Kniesel U, Wolburg H. Tight junctions of the blood-brain barrier. Cell Mol Neurobiol 2000; 20: 57-76. (Pubitemid 30090916)
72. Hofman P, Blaauwgeers HG, Tolentino MJ, Adamis AP, Nunes Cardozo BJ, Vrensen GF et al. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenstrations. Curr Eye Res 2000; 21: 637-45.
73. Fischer S, Wiesnet M, Marti HH, Renz D, Schaper W. Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells. J Cell Physiol 2004; 198: 359-69. (Pubitemid 38235031)
74. Amburgey OA, Chapman AC, May V, Bernstein IM, Cipolla MJ. Plasma from preeclamptic women increases blood-brain barrier permeability: role of vascular endothelial growth factor signaling. Hypertension 2010; 56: 1003-1008.
75. Cipolla MJ. The Cerebral Circulation. In: Granger DN, Granger J (eds) Integrated Systems Physiology - from Molecule to Function. Morgan & Claypool Life Sciences Publishers, San Rafael, CA, 2009; 1-59
76. Matthiesen L, Berg G, Ernerudh J, Ekerfelt C, Jonsson Y, Sharma S. Immunology of preeclampsia. Chem Immunol Allergy 2005; 89: 49-61. (Pubitemid 43154884)
77. Cackovic M, Buhimschi CS, Zhao G, Funai EF, Norwitz ER, Kuczynski E et al. Fractional excretion of tumor necrosis factor-alpha in women with severe preeclampsia. Obstet Gynecol 2008; 112: 93-100.
78. Jonsson Y, Rub̀er M, Matthiesen L, Berg G, Nieminen K, Sharma S et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006; 70: 83-91.
79. Pan W, Csernus B, Kastin AJ. Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier. J Mol Neurosci 2003; 21: 173-84. (Pubitemid 37421620)
80. Pan W, Kastin AJ. Tumor necrosis factor and stroke: role of the blood-brain barrier. Prog Neurobiol 2007; 83: 363-374. (Pubitemid 350116341)
81. Oppenheim JJ, Feldmann M. Introduction to the role of cytokines in innate host defense and adaptive immunity. In: Oppenheim JJ, Feldmann M (eds) Cytokine Reference, Vol. 1 New York, Academic Press, 2001; 3-20.
82. Riazi K, Galic MA, Kuzmiski JB, Ho W, Sharkey KA, Pittman QJ. Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci U S A 2008; 105: 17151-7156.
83. D'Mello C, Le T, SwainMG. Cerebral microglia recruitmonocytes into the brain in response to tumor necrosis factor-alpha signaling during peripheral organ inflammation. J Neurosci 2009; 29: 2089-102.
84. Rossi B, Angiari S, Zenaro E, Budui SL,ConstantinG. Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions. J Leukoc Biol 2010; Dec 17. Doi:10.1189/jlb.0710432.
85. Stellwagen D, Beattie EC, Seo JY, Malenka RC. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 2005; 25: 3219-228. (Pubitemid 40463557)
86. Ishibashi K, KuwaharaM, Sasaki S.Molecular biology of aquaporins. Rev Physiol Biochem Pharmacol 2000; 141: 1-32.
87. Agre P, Bonhivers M, Borgnia MJ. The aquaporins, blueprints for cellular plumbing systems. J Biol Chem 1998; 273: 14659-4662. (Pubitemid 28272745)
88. Verkman AS. Aquaporin water channels and endothelial cell function. J Anat 2002; 200: 617-27. (Pubitemid 34823053)
89. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nature Reviews Neuroscience 2003; 4: 991-1001. (Pubitemid 37486675)
90. Hasegawa H,Ma T, Skach W, Matthay MA, Verkman AS.Molecular cloning of amercurial-insensitive water channel expressed in selected water-transporting tissues. J Biol Chem 1994; 269: 5497-500. (Pubitemid 24242908)
91. Jung JS, Bhat RV, Preston GM, Guggino WB, Baraban JM, Agre P. Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci USA 1994; 91: 13052-3056.
92. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP. Specialized membrane domains for water transport in glial cells: High-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997; 17: 171-80. (Pubitemid 27008860)
93. Amiry-MoghaddamM, Xue R, Haug F-M, Neely JD, Bhardwaj A, Agre P et al. Alpha syntrophin deletion removes the perivascular but not the endothelial pool of aquaporin-4 at the blood-brain barrier and delays the development of brain edema in an experimental model of acute hyponatremia. FASEB J 2004; 18: 542-44.
94. Amiry-Moghaddam M, Otuska T, Hurn PD, Traystman RJ, Haug F-M, Froehner SC et al. An alphasyntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain. Proc Natl Acad Sci USA 2003; 100: 2106-111. (Pubitemid 36254581)
95. Saadoun S, Papadopoulos MC, Davies DC, Krishna S, Bell BA. Aquaporin-4 expression is increased in oedematous human brain tumors. J Neurol Neurosurg Psychiat 2002; 72: 262-65.
96. Taniguchi M, Yamashita T, Kumura E, Tamatani M, Kobayashi A, Yokawa T et al. Induction of aquaporin-4 water channel mRNA after focal cerebral ischaemia in rat. Mol Brain Res 2000; 78: 131-37. (Pubitemid 30417493)
97. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nature Med 2000; 6: 159-63. (Pubitemid 30082359)
98. Vizuete ML, Venero JL, Vargas C, Ilundain AA, Echevarria M, Machado A, Cano J. Differential upregulation of aquaporin-4 mRNA expression in reactive astrocytes after brain injury: potential role in brain edema. Neurobiol Dis 1999; 6: 245-58. (Pubitemid 29470036)
99. Quick AM, Cipolla MJ. Pregnancy-induced upregulation of aquaporin-4 protein in brain and its role in eclampsia. FASEB J 2005; 19: 170-75. (Pubitemid 40189258)
100. Wiegman MJ, Bullinger LV, Kohlmeyer MM, Hunter TC, Cipolla MJ. Regional expression of aquaporin 1, 4, and 9 in the brain during pregnancy. Reprod Sci 2008; 15: 506-16. (Pubitemid 351832774)
101. Binder DK, Yao X, Verkman AS, Manley GT. Increased seizure duration in mice lacking aquaporin-4 water channels. Acta Neurochir Suppl 2006; 96: 389-92.
102. Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost 2009; 7: 375-84.
103. Sankaralingam S, Xu Y, Sawamura T, Davidge ST. Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite. Hypertension 2009; 53: 270-77.
104. Roberts JM, Hubel CA. Oxidative stress in preeclampsia. Am J Obstet Gynecol 2004; 190: 1177-178. (Pubitemid 38692192)
105. Shaner MD. Neurological Problems of Pregnancy. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD (eds) Neurology in Clinical Practice. Edited by Third Ed. Vol. II, Butterworth-Heinemann, Boston, 2000; 2257-267.
106. Aukes AM, de Groot JC, Aarnoudse JG, Zeeman GG. Brain lesions several years after eclampsia. Am J Obstet Gynecol 2009; 200: 504.e1-5.
107. Aukes AM, Wessel I, Dubois AM, Aarnoudse JG, Zeeman GG. Self-reported cognitive functioning in formerly eclamptic women. Am J Obstet Gynecol 2007; 197: 365.e1-6.
108. Postma IR,Wessel I, Aarnoudse JG, Zeeman GG. Neurocognitive functioning in women with a history of eclampsia: executive functioning and sustained attention. Am J Perinatol 2010; 27: 685-90.
109. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201-205.
110. Chien PFW, Khan KS, Arnott N. Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: An overview of the evidence from randomised trials. Br J Obstet Gynaecol 1996; 103: 1085-1091. (Pubitemid 26371053)
111. Duley L,Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia.CochraneDatabase Syst Rev 2003; 4.
112. Ramanathan J, Sibai BM, Pillai R, Angel JJ. Neuromuscular transmission studies in preeclamptic women receiving magnesium sulfate. Am J Obstet Gynecol 1988; 158: 40-46. (Pubitemid 18043332)
113. Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: Evalauation of 235 cases. Am J Obstet Gynecol 1984; 148: 951-60.
114. Altura BM, Altura BT, Carella A, Gebrewold A, Murakawa T, Nishio A. Mg2+ - Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol 1987; 65: 729-45. (Pubitemid 17106640)
115. Euser AG, Cipolla MJ. Resistance artery vasodilation to magnesium sulfate during pregnancy and the postpartum state. Am J Physiol Heart Circ Physiol 2005; 288: H1521-H1525. (Pubitemid 40417970)
116. Euser AG, Bullinger L, Cipolla MJ. Magnesium sulphate treatment decreases blood brain barrier permeability during acute hypertension in pregnant rats. Exp Physiol 2008; 93: 254-61.
117. Hallak M, Berman RF, Irtenkauf SM, Janusz C, Cotton DB. Magnesium sulfate treatment decreases N-methyl-D-aspartate receptor binding in the rat brain: An autoradiographic study. J Soc Gynecol Invest 1994; 1: 25-30. (Pubitemid 2064192)